An Phase I Study of YY001 in Patients with Advanced Solid Tumors

Clinical trial NCT06228846 · COMPLETED

Trial details

NCT number: NCT06228846
Sponsor: Shanghai Yuyao Biotech Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-07-14
Primary completion: 2024-04-30
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.